Summary
- Current Price
- As of today, LENZ price is $9.67, up +3.42% on
- Current Price All-Time High
- LENZ price is currently -80.81% below its historical high of $50.40 set on
- Market Cap
- LENZ current market cap is $303M, down -56.93% year-over-year
- PE Ratio
- LENZ PE ratio is unknown
- Revenue
- LENZ current annual revenue is $19.09M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for LENZ is on
Profile
| Metric | Value |
|---|---|
| Full Name | LENZ Therapeutics, Inc. |
| Ticker | NASDAQ: LENZ |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lenz-tx.com |
| Employees | 6 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.67 | |
| Price, 1D Change | +3.42% | |
| $303M | ||
| - | ||
| - | ||
| 1.62 | ||
| $19M | ||
| Revenue, 1Y Change | +100.00% | |
| -$2.85 | ||
| EPS, 1Y Change | -21.88% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.03 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:7 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GRPH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.85 | ||
| EPS Estimate | N/A | -$3.79 |
| EPS Est. Change | N/A | -33.02% |
| $19.09M | ||
| Revenue Estimate | N/A | $28.32M |
| Revenue Est. Change | N/A | +48.38% |
| Current Price | $9.67 | |
| Price Target | - | $39.00 |
| Price Tgt. Change | - | +303.31% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.87 | -$2.34 | -24.76% | |
| -$2.58 | -$2.85 | -10.34% | |
| -$3.79 | N/A | -33.02% | |
| -$2.63 | N/A | +7.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $19.52M | $19.09M | -2.20% | |
| $28.32M | N/A | +48.38% | |
| $84.50M | N/A | +342.68% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.67 | |
| $26.82 | ||
| SMA 200 vs Price | +177.31% | |
| $13.08 | ||
| SMA 50 vs Price | +35.30% | |
| 1.62 | ||
| $0.98 | ||
| 39.31 | ||
| 126.02% | ||
| 83.16% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.03 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $19.09M | ||
| -$2.85 | ||
| $18.67M | ||
| 96.31% | ||
| -$91.14M | ||
| -477.46% | ||
| -$82.13M | ||
| -430.25% | ||
| -$90.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 14.23 | ||
| 14.09 | ||
| - | ||
| - | ||
| 7.57 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 15.85 | ||
| 1.06 | ||
| -0.12 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $284.34M | ||
| $292.35M | ||
| $305.88M | ||
| $301.41M | ||
| $21.54M | ||
| $21.19M | ||
| $815.00K | ||
| $465.00K | ||
| $4.17M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $101.22M | ||
| $109.81M | ||
| $418.00K | ||
| $0.00 | ||
| $287.00K | ||
| $0.00 | ||
| $502.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$69.17M | ||
| -$75.67M | ||
| $149.75M | ||
| $827.00K | ||
| -$70.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| B of A Securities | → | |
| Raymond James | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Raymond James | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with LENZ
FAQ
What is the ticker symbol for LENZ Therapeutics, Inc.?
The ticker symbol for LENZ Therapeutics, Inc. is NASDAQ:LENZ
Does LENZ Therapeutics, Inc. pay dividends?
No, LENZ Therapeutics, Inc. does not pay dividends
What sector is LENZ Therapeutics, Inc. in?
LENZ Therapeutics, Inc. is in the Healthcare sector
What industry is LENZ Therapeutics, Inc. in?
LENZ Therapeutics, Inc. is in the Biotechnology industry
What country is LENZ Therapeutics, Inc. based in?
LENZ Therapeutics, Inc. is headquartered in United States
When did LENZ Therapeutics, Inc. go public?
LENZ Therapeutics, Inc. initial public offering (IPO) was on March 22, 2024
Is LENZ Therapeutics, Inc. in the S&P 500?
No, LENZ Therapeutics, Inc. is not included in the S&P 500 index
Is LENZ Therapeutics, Inc. in the NASDAQ 100?
No, LENZ Therapeutics, Inc. is not included in the NASDAQ 100 index
Is LENZ Therapeutics, Inc. in the Dow Jones?
No, LENZ Therapeutics, Inc. is not included in the Dow Jones index
When was LENZ Therapeutics, Inc. last earnings report?
LENZ Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does LENZ Therapeutics, Inc. report earnings?
The next expected earnings date for LENZ Therapeutics, Inc. is May 6, 2026
Data Sources & References
- LENZ Official Website www.lenz-tx.com
- LENZ Profile on Yahoo Finance finance.yahoo.com/quote/LENZ
- LENZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lenz